IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes (RENALIS)
This study has been completed.
Sponsor:
VU University Medical Center
Information provided by (Responsible Party):
M.H.H. Kramer, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT02106104
First received: March 28, 2014
Last updated: May 16, 2016
Last verified: May 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2016 |
| Primary Completion Date: | April 2016 (Final data collection date for primary outcome measure) |